1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,004 | 0,026 | 18:24 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.08. | PreveCeutical Medical Inc.: PreveCeutical Closes Fourth Tranche of Non-Brokered Private Placement | 528 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 28.07. | Preveceutical Medical Inc: Preveceutical Medical closes third tranche of financing | 3 | Stockwatch | ||
| 27.07. | PreveCeutical Medical Inc.: PreveCeutical Closes Third Tranche of Non-Brokered Private Placement | 403 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 13.06. | Preveceutical Medical Inc: Preveceutical closes $245K second tranche of placement | 4 | Stockwatch | ||
| 12.06. | PreveCeutical Medical Inc.: PreveCeutical Closes Second Tranche of Non-Brokered Private Placement | 872 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 08.06. | Preveceutical Medical Inc: Preveceutical investment BioGene names Howton director | 6 | Stockwatch | ||
| PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln | |||||
| 08.06. | PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors | 623 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 8, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical"), a health sciences company that develops innovative... ► Artikel lesen | |
| 20.05. | PreveCeutical Medical Inc.: PreveCeutical Announces Extension of Non-Brokered Private Placement | 734 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that,... ► Artikel lesen | |
| 12.05. | PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement | 550 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that,... ► Artikel lesen | |
| 22.04. | Preveceutical Medical Inc: Preveceutical arranges $1-million private placement | 4 | Stockwatch | ||
| 22.04. | PreveCeutical Medical Inc.: PreveCeutical Announces Non-Brokered Private Placement | 531 | Newsfile | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - PreveCeutical Medical Inc. (CSE:... ► Artikel lesen | |
| 01.04. | PreveCeutical Medical Inc.: PreveCeutical Adopts Semi-Annual Financial Reporting | 602 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected... ► Artikel lesen | |
| 30.03. | Preveceutical Medical Inc: Preveceutical appoints Pruthi as director | 4 | Stockwatch | ||
| 30.03. | PreveCeutical Medical Inc.: PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director | 488 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical" or the "Company"), a health sciences company that... ► Artikel lesen | |
| 12.03. | Preveceutical Medical Inc: Preveceutical investment BioGene names Pruthi director | 3 | Stockwatch | ||
| 25.02. | Preveceutical Medical Inc: Preveceutical receives Canadian patent allowance | 4 | Stockwatch | ||
| 25.02. | PreveCeutical Medical Inc.: PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology | 652 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 25, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that... ► Artikel lesen | |
| 09.02. | PreveCeutical Medical Inc.: PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents | 437 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it... ► Artikel lesen | |
| 04.12.25 | PreveCeutical Medical Inc.: PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology | 449 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that... ► Artikel lesen | |
| 27.11.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 27.11.2025 | 813 | Xetra Newsboard | The following instruments on XETRA do have their first trading 27.11.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 27.11.2025
Aktien
1 CNE100003KK7 Rizhao Port Jurong Co.... ► Artikel lesen |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,730 | -0,01 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Fresenius von 54 auf 56 Euro angehoben und die Einstufung auf "Buy" belassen. Das zweite Quartal könne für den Gesundheitskonzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,720 | -0,17 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,460 | +1,18 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Siemens Healthineers von 38 auf 39 Euro angehoben und die Einstufung auf "Hold" belassen. Nach einem gemischten Quartal des... ► Artikel lesen | |
| INTUITIVE SURGICAL | 344,25 | +2,11 % | Oppenheimer Just Upgraded Intuitive Surgical Stock. Here's Why. | ||
| DRAEGERWERK | 110,20 | +0,92 % | dpa-AFX-Überblick: UNTERNEHMEN vom 10.08.2026 - 15.15 Uhr | ROUNDUP: Hypoport bestätigt Jahresziele für 2026 - Aktie legt zu BERLIN - Der Finanzdienstleister Hypoport sieht sich auf Kurs zu seinen Jahreszielen. "Die geopolitischen Spannungen des ersten Halbjahres... ► Artikel lesen | |
| MEDTRONIC | 79,82 | +1,99 % | Medtronic: What Experts Really Say About Overactive Bladder | Breaking down the myths, realities, and innovations shaping pelvic healthcare today. NORTHAMPTON, MA / ACCESS Newswire / August 18, 2026 / Bladder leaks, frequent trips to the bathroom, and pelvic discomfort... ► Artikel lesen | |
| THERMO FISHER | 506,60 | +0,16 % | Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist | The transaction establishes an independent company, with the Microbiology business providing the foundation of a global microbiology diagnostics platform serving the clinical, food safety and... ► Artikel lesen | |
| TELADOC HEALTH | 5,590 | -0,96 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,063 | -1,88 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| FAMICORD | 2,850 | +2,52 % | EQS-News: FamiCord AG wechselt mit Wirkung zum 19. August 2026 ins Scale Segment | EQS-News: FamiCord AG
/ Schlagwort(e): Zulassungsgenehmigung
FamiCord AG wechselt mit Wirkung zum 19. August 2026 ins Scale Segment
18.08.2026 / 09:27 CET/CEST
Für den... ► Artikel lesen | |
| PROFUSA | 10,400 | +129,58 % | Profusa, Inc.: Profusa Announces 1-for-4 Reverse Stock Split | BERKELEY, California, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa" or the "Company") (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform... ► Artikel lesen | |
| HEARTFLOW | 44,690 | +6,56 % | Heartflow, Inc.: Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,220 | +0,13 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec von "Neutral" auf "Sell" abgestuft und das Kursziel von 25,00 auf 22,60 Euro gesenkt. Für das Optoelektronik-Unternehmen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,72 | -1,09 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| GERRESHEIMER | 27,980 | +0,72 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen |
PREVECEUTICAL MEDICAL INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,009 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PREVECEUTICAL MEDICAL INC finden Sie auf Wallstreet Online.